Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897702 · ClinicalTrials.gov registry record
Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 269
- Enrollment target
NCT00897702: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00897702 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 269 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00897702 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 269 participants
- Enrollment target
Study Summary
The purpose of this study is to learn why certain drugs stop working in patients.In lab studies, tumors become resistant in several ways. Specific molecules seem to change and this may be why therapy stops working. However, we do not know if the same molecules change in patients. This study is being done to see if they do change. If we learn more about how patients become resistant, we may be able to offer better treatment in the future.
Interventions
- OTHER Blood draw
- PROCEDURE biopsy
- OTHER immunoenzyme technique
- PROCEDURE histopathologic examination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 269 participants |
| Start Date | 2007-01-09 |
| Est. Completion | 2026-01-23 |
What the finished NCT00897702 record still lists
NCT00897702 is an observational study that tracks outcomes without assigning an intervention. The registered 269 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which Blood draw is the first listed.
NCT00897702 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00897702 about?
NCT00897702 is a clinical study titled "Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer". The purpose of this study is to learn why certain drugs stop working in patients.In lab studies, tumors become resistant in several ways. Specific molecules seem to change and this may be why therapy stops working. However, we do not know if the same molecules change in patients. This study is being...
What is the current status of trial NCT00897702?
This trial is currently completed. The enrollment target is 269 participants. The study started on 2007-01-09. Estimated completion is 2026-01-23.
What interventions are being tested in trial NCT00897702?
The interventions under investigation include: Blood draw (OTHER), biopsy (PROCEDURE), immunoenzyme technique (OTHER), histopathologic examination (PROCEDURE).
Who is sponsoring clinical trial NCT00897702?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04802291 · 269 participants · NA
HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity
- NCT06500455 · 269 participants · Phase 3
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
- NCT06630676 · 269 participants · NA
The Ability of Chronic Pain Patients to Self-diagnose Their Chief Source of Low Back Pain
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI